Friday, 16 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 30, 2026

Stock market today: Dow rises, S&P 500 and Nasdaq slip as war uncertainty drives oil prices higher

View original at finance.yahoo.com
Stock market today: Dow rises, S&P 500 and Nasdaq slip as war uncertainty drives oil prices higher US stocks diverged on Monday as oil climbed and Wall Street headed into a holiday-shortened trading week, with investors bracing for fresh economic data amid lingering consumer uncertainty…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • We believe we will see a bottom in crypto stocks into weak Q1 earnings

    60% confidence
  • The tendency is to look through any kind of a supply shock, though the critical point is to monitor inflation expectations

    60% confidence
  • These businesses offer exposure to trillion dollar markets with years of growth ahead - prediction markets, stablecoins, tokenized real world assets, crypto derivatives and further beta on crypto recovery from the bottom

    60% confidence
  • Inflation expectations remain well anchored beyond the short term

    60% confidence
  • Energy shocks have tended to come and go pretty quickly

    60% confidence
  • Absent impacts from fuel, Puerto Vallarta, and Hawaii storms, Air Group's results would have exceeded the midpoint of original guidance

    60% confidence
  • The US is in serious discussions to end the military operation in Iran

    60% confidence
  • Over time, the US is going to retake control of the straits, and there will be freedom of navigation — whether it is through US escorts or a multinational escort

    60% confidence
  • Fuel cost surge will lead to a drag on earnings per share of at least $0.70

    60% confidence
  • The combination of geopolitics and temporary crypto weak sentiment is offering big discounts on crypto stocks

    60% confidence
  • We will eventually face the question of what to do here, but we're not facing them yet because we don't know what the economic effects will be

    60% confidence
  • By the time the effects of tightening in monetary policy take effect, the oil price shock is probably long gone, and you're weighing on the economy at a time when it's not appropriate

    60% confidence
  • Coinbase's earnings per share will grow by 23% in 2026, driven by a stablecoin boom, new product launches, and an expected crypto recovery

    60% confidence
  • The refining margins on fuel from Singapore have surged by roughly 400% since early February

    60% confidence
  • Preference would be for the US to control the oil industry in Iran indefinitely

    60% confidence
  • If a deal is not reached shortly, the US would obliterate Iran's key desalination and energy infrastructure

    60% confidence

Data points we hold from this source

UBS Group AG · shares held533824 shares
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com
Stock market today: Dow rises, S&P 500 and Nasdaq slip as war uncertainty drives oil prices higher — Source | Via News | ViaNews EU